Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 28
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study | Germain M, Grégoire Y, Custer BS, Goldman M, Bravo M, Kamel H, Davison K, Field S, van den Hurk K, van de Laar TJW, Irving DO, Jones A, Liumbruno G, Morley S, O’Brien SF, Pillonel J, Steinsvåg CT, Takanashi M, Tsuno NH, Vesga Carasa MA, Wendel S, Vassallo RR, Tiberghien P, for the BEST Collaborative | 2021 | Vox Sang | View An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study | Researchers | Benchmarking and standard setting |
Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Bartoszko J | 2021 | Blood.ca website | View Concentré de recherche: L’administration d’albumine par voie intraveineuse ne conduit pas à de meilleurs résultats chez les personnes subissant des opérations cardiaques | Health care providers | Clinical research |
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P | 2021 | Allergy | View Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Health care providers | Basic research |
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Al-Riyami AZ, Jug R, La Rocca U, Keshavarz H, Landry D, Shehata N, Stanworth SJ, Nahirniak S | 2021 | Transfusion | View Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Researchers | Benchmarking and standard setting |
Themed issue – focusing on donor assessment, motivation and vigilance | O’Brien SF, Ullum H, Seed CR | 2021 | Vox Sang | View Themed issue – focusing on donor assessment, motivation and vigilance | Researchers | New or improved product or process |
Adverse reactions reporting | Yan M | 2021 | Blood.ca website | View Adverse reactions reporting | Health care providers | Benchmarking and standard setting |
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Sun H, Yang M, Poon M-C, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S | 2021 | Haemophilia | View Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Researchers | Clinical research |
Challenging the 30-min rule for thawed plasma | Ramirez-Arcos S, Howell A, Bearne J, Bhakta V, Bower L, Cardigan R, Girard M, Kou Y, McDonald C, Nolin M-È, Sawicka D, Sheffield W | 2021 | Vox Sang | View Challenging the 30-min rule for thawed plasma | Researchers | Benchmarking and standard setting |
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J | 2021 | CMAJ Open | View What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Health care providers | Benchmarking and standard setting |
How do I think about blood donor eligibility criteria for medical conditions? | Goldman M | 2021 | Transfusion | View How do I think about blood donor eligibility criteria for medical conditions? | Researchers | Benchmarking and standard setting |
ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Batarfi K | 2021 | Blood.ca website | View ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia | Researchers | Clinical research |
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LSH, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima KM, Speedy J, Bruun MT, Dunbar NM | 2021 | Vox Sang | View International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses | Health care providers | Benchmarking and standard setting |
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Viana R, D'Alessio D, Grant L, Cooper N, Arnold D, Morgan M, Provan D, Cuker A, Hill QA, Tomiyama Y, Ghanima W | 2021 | Adv Ther | View Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia | Researchers | Clinical research |
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Sirotich E, Guyatt G, Gabe C, Ye Z, Beck CE, Breakey V, Cooper N, Cuker A, Charness J, de Wit K, DiRaimo J, Fein SG, Grace RF, Hassan Z, Jamula E, Kang M, Manski CF, O'Connor C, Pai M, Paynter D, Porter SC, Pruitt B, Strachan G, Webert KE, Yan JW, Kelton JG, Bakchoul T, Arnold DM | 2021 | J Thromb Haemost | View Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Risk of transfusion-transmitted Babesia microti in Canada | O'Brien SF, Drews SJ, Yi Q-L, Bloch EM, Ogden NH, Koffi JK, Lindsay LR, Gregoire Y, Delage G | 2021 | Transfusion | View Risk of transfusion-transmitted Babesia microti in Canada | Researchers | Benchmarking and standard setting |
Réactions transfusionnelles anaphylactiques et déficit en IgA | Khandelwal A, Clarke G, Goldman M | 2021 | Blood.ca website | View Réactions transfusionnelles anaphylactiques et déficit en IgA | Health care providers | Benchmarking and standard setting |
Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Dunbar NM, Kaufman RM | 2021 | Transfusion | View Factors associated with wrong blood in tube errors: An international case series - The BEST collaborative study | Health care providers | Benchmarking and standard setting |
Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Branch DR, Sandhu G, Raos M | 2021 | Transfusion | View Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing | Researchers | New or improved product or process |
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So – Osman C, Wood E, Devine DV, Spitalnik SL, the ISBT COVID-19 Working Group | 2021 | Vox Sang | View ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group | Researchers | Clinical research |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Stewart T | 2021 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Health care providers | Benchmarking and standard setting |
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D | 2021 | Cochrane Database Syst Rev | View Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Health care providers | Clinical research |
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee C-K, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C | 2021 | Vox Sang | View Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Blood operators | New or improved product or process |
Chapter 11: Massive hemorrhage and emergency transfusion | Trudeau J, Dawe P, Shih A | 2021 | Clinical Guide to Transfusion | View Chapter 11: Massive hemorrhage and emergency transfusion | Health care providers | Benchmarking and standard setting |
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Saeed S, Uzicanin S, Lewin A, Lieshout-Krikke R, Faddy H, Erikstrup C, Osiowy C, Seed C, Steele W, Davidson K, Custer B, O’Brien S, Assessment ObotSR, Policy sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion | 2021 | medRxiv | View Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review | Researchers | Basic research |
International Forum on Walking Blood Bank Programmes: Summary | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Sekaran Nadarajan V, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Summary | Blood operators | Benchmarking and standard setting |
CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Kapopara PR, Safikhan NS, Huang JL, Meixner SC, Gonzalez K, Loghmani H, Ruf W, Mast AE, Lei V, Pryzdial ELG, Conway EM | 2021 | J Thromb Haemost | View CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models | Researchers | Basic research |
Rethinking platelet transfusion practices | Devine DV | 2021 | Blood | View Rethinking platelet transfusion practices | Health care providers | New or improved product or process |
Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Arnold DM, for The CONCOR-1 Study Group | 2021 | medRxiv | View Convalescent plasma for hospitalized patients with COVID-19 and the effect of plasma antibodies: a randomized controlled, open-label trial | Health care providers | Clinical research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
FcgammaRI and FcgammaRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia | Norris PAA, Segel GB, Burack WR, Sachs UJ, Lissenberg-Thunnissen SN, Vidarsson G, Bayat B, Cserti-Gazdewich CM, Callum J, Lin Y, Branch D, Kapur R, Semple JW, Lazarus AH | 2021 | Haematologica | View FcgammaRI and FcgammaRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia | Researchers | Basic research |
Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol | Fergusson DA, Chassé M, Tinmouth A, Acker JP, English S, Forster AJ, Hawken S, Shehata N, Thavorn K, Wilson K, Tuttle A, Perelman I, Cober N, Maddison H, Tokessy M | 2021 | BMJ Open | View Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol | Researchers | Clinical research |
DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Vappala S, Straus S, Pryzdial EL, Conway E, Kizhakkedathu J | 2021 | Blood | View DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Researchers | Basic research |
Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Schubert P, Johnson L, Culibrk B, Chen Z, Tan S, Marks DC, Devine DV | 2021 | Transfusion | View Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Researchers | New or improved product or process |
Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Modi D | 2021 | Ontario Regional Blood Coordinating Network December 2021 Newsletter | View Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Health care providers | Clinical research |
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O'Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM | 2021 | Clin Infect Dis | View A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Researchers | Clinical research |
Chapter 6: Donor selection, donor testing and pathogen reduction | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Clinical Guide to Transfusion | View Chapter 6: Donor selection, donor testing and pathogen reduction | Health care providers | Benchmarking and standard setting |
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blake JT, McTaggart K, Couture C | 2021 | Transfusion | View Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blood operators | Benchmarking and standard setting |
Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Parvizian MK, Barty R, Heddle NM, Li N, McDougall T, Mukerji A, Fusch C, Solh Z | 2021 | Transfusion | View Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood | Researchers | Clinical research |
Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Lewis BJB, Binnington B, Blacquiere M, Spirig R, Käsermann F, Branch DR | 2021 | eJHaem | View Mechanism of increased efficacy of recombinant Fc-?TP-L309C compared to IVIg to ameliorate mouse immune thrombocytopenia | Researchers | Basic research |
Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Gaussen A, Hornby L, Rockl G, O’Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A | 2021 | Transplantation | View Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation | Health care providers | Clinical research |
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Choi PY, Grace RF, Therese Ahlen M, Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Althaus K, Sharma R, Bakchoul T | 2021 | J Thromb Haemost | View The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters | Researchers | Benchmarking and standard setting |
ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Bartoszko J | 2021 | Blood.ca website | View ResearchUnit: Intravenous albumin is not associated with improved outcomes in cardiac surgery patients | Health care providers | Clinical research |
Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Khayyat H, Callum JL, Hill-Strathy M, Strauss R, Notario L, Nathens A, da Luz L | 2021 | Can J Anaesth | View Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Health care providers | Clinical research |
Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Vijenthira S, Armali C, Downie H, Wilson A, Paton K, Berry B, Wu HX, Robitaille A, Cserti-Gazdewich C, Callum J | 2021 | Vox Sang | View Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Health care providers | Clinical research |
Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Xu X, Chen D, Ye X, Xia W, Xu Y, Chen Y, Shao Y, Deng J, Ding H, Liu J, Wang J, Ni H, Fu Y, Santoso S | 2021 | Blood | View Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Researchers | Basic research |
Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Strauss R, Menchetti I, Perrier L, Blondal E, Peng H, Sullivan-Kwantes W, Tien H, Nathens A, Beckett A, Callum J, da Luz LT | 2021 | Trauma Surg Acute Care Open | View Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Health care providers | Clinical research |
Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Prokopchuk-Gauk O, Solh Z | 2021 | Guide de la pratique transfusionnelle | View Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Health care providers | Benchmarking and standard setting |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Irvine MA, Reicherz F, Coombs D, O’Reilly C, Sediqi S, Razzaghian HR, Sadarangani M, O’Brien SF, Lavoie PM | 2021 | medRxiv | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Researchers | Clinical research |